Ex Vivo and In Vivo Characterization of Interpolymeric Blend/Nanoenabled Gastroretentive Levodopa Delivery Systems

Table 3

Measurement of total cytotoxicity (step 2).

Samples	Well 1	Well 2	Well 3	Well 4	Well 5	Well 6
10 mg nanoparticles	778	744	834	924	832	868
10 mg IPB	1676	1662	1576	1414	1628	1836
Cells only	2784	2344	2810	2404	2576	2810
Fresh medium	118	108	102	92	80	118
Empty wells	150	164	148	172	144	116